Sepracor, Inc. Announces Presentation Of LUNESTA(TM) Data At Associated Professional Sleep Societies Annual Meeting

MARLBOROUGH, Mass.--(BUSINESS WIRE)--June 13, 2006--Sepracor Inc. (Nasdaq: SEPR - News) today announced that data for LUNESTA(TM) brand eszopiclone for the treatment of insomnia will be presented at the SLEEP 2006 20th Anniversary Meeting of the Associated Professional Sleep Societies at the Salt Palace Convention Center in Salt Lake City on June 20th and 22nd. There will be four oral presentations and four posters presented.

Back to news